Clamoxin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clamoxin

What is Clamoxin? The Identity and Purpose of Co-amoxiclav

Property Description
Active ingredient Amoxicillin and Clavulanic Acid (Potassium Clavulanate)
Form Oral (Tablets, Suspension, Syrup)
Pharmacological class beta-lactam/beta-lactamase Inhibitor Antibiotic
General purpose To treat bacterial infections
Origin Semisynthetic (Penicillin derivative)

Clamoxin is a combination drug, generically known as Amoxicillin and Clavulanic Acid or Co-amoxiclav, which is used to fight bacterial infections. It is classified as a systemic antibacterial belonging to the beta-lactam/beta-lactamase inhibitor group of antibiotics, a category clinically recognized for its expanded activity spectrum compared to single-agent penicillins. This classification confirms the formulation's specialized role against bacterial pathogens.

The product consists of two distinct active ingredients: the antibiotic Amoxicillin, which is a semisynthetic penicillin derivative, and Clavulanic Acid (often as Potassium Clavulanate), which serves a protective role. The inclusion of Clavulanic Acid fundamentally differentiates this product from single-agent penicillins like Amoxicillin alone.


Composition and Available Dosage Forms

The core composition is built on Amoxicillin, which actively kills bacteria, and Clavulanic Acid, which acts as a protective agent. Clavulanic Acid functions by neutralizing the bacterial enzyme beta-lactamase, which would otherwise destroy the Amoxicillin. This mechanism effectively protects Amoxicillin from degradation.

This medicine is available for the general population in multiple common oral formulations, typically including film-coated tablets, chewable tablets, and a liquid oral suspension (syrup) formulated with an aqueous vehicle. The availability of liquid suspension is essential for pediatric-focused use in children with bacterial illnesses.


General Purpose: Why is Clamoxin Used?

The general purpose of Clamoxin is to provide effective broad-spectrum antibacterial action against susceptible bacteria that cause illness. The dual-agent design is critical for overcoming bacterial resistance. This combination is specifically intended to restore the clinical effectiveness of Amoxicillin in the presence of bacteria that produce the beta-lactamase enzyme, allowing for the reliable elimination of pathogens.

What side effects are possible with Clamoxin?

Possible Side Effects and Safety Information

Clamoxin (Amoxicillin and Clavulanate Potassium) is generally well-tolerated, but regulatory sources document a spectrum of potential adverse reactions, ranging from common to rare and serious.


Adverse Reactions Summary

Common reactions typically involve the Gastrointestinal system, with diarrhea being the most frequently reported event. Other common effects include nausea and vomiting. Administration with a meal may help mitigate gastrointestinal intolerance.

Clinically Significant and Serious Adverse Reactions

Serious, occasionally fatal Hypersensitivity Reactions (e.g., anaphylaxis, severe rash) are a known risk, particularly in individuals with a history of allergy to penicillin antibiotics. The drug is strictly contraindicated in these patients.

  • Hepatobiliary Disorders: Liver dysfunction, including cholestatic jaundice and hepatitis, has been reported. These events can be severe and may occur during treatment or up to several weeks after cessation, predominantly affecting males and the elderly. Use is contraindicated in patients with a history of hepatic dysfunction related to this drug combination.
  • Clostridium difficile-associated diarrhea (CDAD): Like other antibiotics, use may lead to overgrowth of C. difficile, causing severe, watery, or bloody diarrhea, which can occur up to two months after discontinuation.
  • Dose-related Concerns: In patients with renal impairment, dose adjustment is often necessary, as high doses or poor renal clearance increase the risk of adverse events like convulsions and amoxicillin crystalluria. Adequate fluid intake is advised to mitigate crystalluria risk.

Safety Restrictions and Precautions

  • Contraindications: History of serious hypersensitivity to penicillins or history of cholestatic jaundice/hepatic dysfunction associated with Amoxicillin/Clavulanate.
  • Cautions: Use with caution in patients with hepatic or renal impairment. Avoid use in patients with infectious mononucleosis due to the high risk of a rash. The drug may potentially reduce the efficacy of oral contraceptives.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below summarizes officially documented overdose patterns for Amoxicillin/Clavulanate (Clamoxin), strictly as described in government regulatory documents.


Documented Overdose Manifestations

Regulatory sources indicate that an overdose may primarily affect the gastrointestinal system, presenting with nausea, vomiting, diarrhea, and stomach pain. Central Nervous System (CNS) effects such as drowsiness and hyperactivity are also documented. A serious risk associated with the Amoxicillin component is crystalluria (crystals in the urine), which can cause decreased urination and lead to acute renal failure.

Severe Outcomes and Emergency Actions

Official labeling warns that convulsions (seizures) may occur in overdose, particularly in patients with impaired renal function or those exposed to very high doses. In any suspected case of overdose, it is mandatory to seek emergency medical attention immediately. Individuals must contact a Poison Help line or emergency services if the person has collapsed, is seizing, or has difficulty breathing.

Management and Monitoring

No specific antidote is known for Clamoxin overdose. Management is officially described as symptomatic and supportive. Regulatory documents state that both active components are removable from the circulation by hemodialysis, a procedure that may be utilized in severe cases. Close hospital monitoring of renal and liver function is often required to manage potential complications.

Therapeutic Uses of Clamoxin

What Clamoxin Treats: Main Uses and Benefits

Clamoxin may be applied to help manage bacterial infections across multiple body systems, providing a broad spectrum of therapeutic support. The medication is commonly used across conditions presenting with acute episodes, including infections of the respiratory tract, the ear, nose, and throat, the skin and soft tissues, and the genitourinary system.

It is applied to help address symptom clusters that may become intense or disruptive, such as fever, localized pain, and swelling related to inflammatory states. This supports patients during difficult episodes by easing distress and contributes to improved comfort during symptomatic periods. In specific clinical scenarios, it is relevant across domains where additional symptomatic support is needed, particularly for serious localized infections like cellulitis, dental abscesses, and other bacterial skin and soft tissue infections.

“Clamoxin assists with maintaining functional stability by providing supportive relief when symptoms interfere with routine activities.”

The therapeutic action supports the management of the infection and contributes to easing the overall symptom load.


Quick Fact: Relevant for Symptoms Related to Physical Discomfort

Regulatory References

  1. Amoxicillin and Clavulanic Acid: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Clamoxin (Amoxicillin/Clavulanate Potassium) is a prescription antibiotic generally used to treat bacterial infections. Determining who can and cannot use this medication is based on medical history, allergies, and existing conditions. Always consult a healthcare provider for personalized advice.

Who Can Use Clamoxin?

Clamoxin is typically prescribed for individuals, including children and adults, with bacterial infections that are susceptible to the drug's components. This includes common infections of the:

  • Respiratory tract (e.g., pneumonia, sinusitis)
  • Ear (e.g., otitis media)
  • Skin and soft tissue
  • Urinary tract

Who Should NOT Use Clamoxin?

The medication is contraindicated for individuals with certain medical histories. Do not use Clamoxin if you have:

  • A known allergy or hypersensitivity to penicillin or any other ingredient in Clamoxin. This includes cross-reactivity with other beta-lactam antibiotics like cephalosporins.
  • A history of jaundice (yellowing of the skin or eyes) or hepatic dysfunction (liver problems) associated with previous use of Clamoxin or amoxicillin/clavulanate.
  • Infectious Mononucleosis (Mono), as it significantly increases the risk of developing a generalized skin rash.

What should I know about interactions with other medicines?

Clamoxin Interactions with other medicines and products

Clamoxin (Amoxicillin/Clavulanic Acid) can interact with several medicinal products and product classes, potentially altering drug concentrations, effectiveness, or the risk of adverse effects. It is important to review all current medications with a healthcare provider.

Key Drug-Drug Interactions

Interacting Product Category Potential Effect Management / Precaution
Oral Anticoagulants (e.g., Warfarin, Acenocoumarol) Risk of abnormal prolongation of prothrombin time (increased INR) and bleeding is increased. Close monitoring of Prothrombin Time/INR is required; anticoagulant dose adjustment may be necessary.
Probenecid (Uricosuric agent) Increases and prolongs the blood levels of the Amoxicillin component due to reduced renal excretion. Co-administration is generally not recommended.
Methotrexate Penicillins, including Amoxicillin, may reduce the excretion of Methotrexate, potentially increasing its concentration and toxicity. Careful monitoring and dose adjustment of Methotrexate should be considered.
Allopurinol (Xanthine oxidase inhibitor) Concurrent use significantly increases the incidence of skin rashes. Use caution; monitor for skin reactions.
Oral Contraceptives May reduce the efficacy of combined oral estrogen/progesterone contraceptives due to an effect on intestinal flora. Additional, non-hormonal contraceptive methods may be required.

Interactions Affecting Lab Tests

High urine concentrations of Amoxicillin may lead to false-positive results for glucose when using copper reduction tests (e.g., Benedict's Solution, Clinitest). Enzymatic glucose oxidase tests are recommended for urine glucose monitoring in patients taking Clamoxin.

Mechanism of Action

Clamoxin is a pharmaceutical agent that operates by competitively binding to the catalytic domain of the enzyme X-Kinase. This high-affinity interaction results in the inhibition of X-Kinase activity, leading to a functional block of the pathway it regulates. This specific enzymatic inhibition subsequently reduces the intracellular synthesis of the downstream mediator Compound Z within target cells. By limiting the availability of Compound Z, Clamoxin alters the crucial signaling cascade that regulates the proliferation, differentiation, and overall activity of both osteoblast (bone-forming) and osteoclast (bone-resorbing) cells. This modification influences the physiological process of skeletal remodeling by shifting the balance of cellular function at the bone matrix.

Dosage and Administration Information

Clamoxin (Amoxicillin and Clavulanate) must be administered according to specific instructions to ensure proper use.

Administration Routes and Scheduling

Clamoxin is approved for oral use, including tablets, chewable tablets, and liquid suspension. It is also available for Intravenous (IV) injection or infusion for severe cases or when oral administration is not possible.

Standard adult regimens typically require a dose of 500 mg/125 mg every 12 hours (BID) or 8 hours (TID), or 875 mg/125 mg every 12 hours, based on the amoxicillin component. The treatment course should generally be 7 to 10 days and must not be extended beyond 14 days without clinical review.

Required Administration Conditions

Condition Instruction
Timing with Food Administer at the start of a meal to enhance the absorption of the clavulanate component and minimize gastrointestinal intolerance.
Handling Suspension The powder for oral suspension requires reconstitution with water and must be shaken well before each measured dose.
Tablet Integrity Standard tablets should be swallowed whole. Extended-Release (XR) tablets may be split but both halves must be taken immediately.

Population-Specific Use Rules

Dosing for pediatric patients is determined based on body weight (mg/kg/day). Dose reduction or adjusted frequency is explicitly required for patients with severe renal impairment (e.g., creatinine clearance < 30 mL/min), with the 875 mg/125 mg dose typically not recommended for this group.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Clamoxin (Co-amoxiclav)

This section summarizes the official research base for Clamoxin, outlining the types of clinical studies, such as randomized controlled trials (RCTs) and systematic reviews, that regulatory bodies rely on. Evidence contributes to the broader evidence landscape regarding how this combination drug was studied.


Evidence for Use in Respiratory Tract Infections (RTIs)

Research examined Clamoxin's role in the management of conditions associated with fluctuating or episodic manifestations, such as Community-Acquired Pneumonia (CAP), sinusitis, and acute bronchitis. Studies monitored various outcomes related to systemic or functional imbalance, examining metrics such as the rate of symptom change and the measurement of bacterial eradication. Research provides insight into short-term changes measured during the study period, especially when applied in research contexts involving fluctuating or unstable symptoms.

Comparative evidence is lacking for a comprehensive set of current first-line treatments in all specific RTI subtypes, and follow-up durations were limited in many core studies.


Evidence for Use in Ear, Nose, and Throat (ENT) Infections

The evidence base for ENT infections, mainly focusing on Acute Otitis Media (AOM) or middle ear infections, includes Randomized Controlled Trials (RCTs) and systematic reviews. Studies monitored outcomes linked to inflammatory or irritative states, such as fever and ear pain, and research examined clinical outcomes related to infection status. Findings describe group patterns related to outcomes describing episodic or acute changes.

Data for certain groups remain insufficient, particularly for comparing Clamoxin to current alternatives in the post-vaccine era. The majority of research focused on short-term change, meaning that long-term effects are not fully established regarding the durability of the response.


Evidence in Special Populations and Research Uncertainty

Research included studies where the agent was evaluated in specific groups, such as children (for ear infections) and older adults (for respiratory infections). Results apply only to the populations studied, and data for certain groups, such as individuals with significant kidney impairment, remain insufficient. Limitations in the research include that follow-up durations were limited in many pivotal trials, and evidence quality varies across studies due to differences in design and the specific populations enrolled.

Key Studies & References

  1. Amoxicillin and Clavulanic Acid: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Clamoxin (FAQ)

Q: What happens if I miss a dose of Clamoxin?

A: Official patient guidance addresses what to do for a missed dose. If the time since the missed dose is short, it is typically advised to take it as soon as remembered. However, if it is nearly time for the next scheduled dose, regulatory instruction is to skip the missed dose and resume the normal schedule. Regulatory guidance generally advises against taking two doses to make up for a single missed dose.

Q: Are there any specific foods I should avoid while using Clamoxin?

A: Official product labeling does not typically list specific foods that must be avoided while using this medication. The instruction is to take the dose at the start of a meal. This timing is generally associated with optimal absorption of the medication and may help to minimize the possibility of gastrointestinal upset.

Q: What does the official documentation say about stopping Clamoxin suddenly?

A: Official prescribing information strongly stresses the importance of completing the full duration of treatment as prescribed by the clinician. The practice supports the goal of fully eradicating the infection and preventing any remaining bacteria from developing resistance. This class of antibiotic does not typically require a gradual reduction in dose.

Q: What are the signs of a severe allergic reaction to Clamoxin?

A: Serious, occasionally fatal hypersensitivity reactions are noted warnings in regulatory documents. Signs can include a widespread rash, fever, or swelling of the face, tongue, or throat, leading to difficulty breathing. Official documentation notes that these reactions are serious events that require timely clinical attention.

Q: What should I do if the side effects of Clamoxin seem to be getting worse?

A: Official regulatory documentation describes specific serious adverse reactions that require timely clinical attention. These include severe or persistent diarrhea, or signs of liver problems, such as yellowing of the skin or eyes. Official safety documentation notes that if side effects intensify or new, severe symptoms appear, this indicates a need for clinical consultation.

Q: Is there a contraindication for using Clamoxin with blood thinners?

A: Official documentation lists the concurrent use of oral anticoagulants (blood thinners) as an interaction that can increase the risk of bleeding. This is specified as an interaction where close monitoring of blood parameters is noted in regulatory information, but it is not formally listed as a contraindication.

Q: What does the patient leaflet say about overdose symptoms for Clamoxin?

A: Symptoms described in regulatory documents following high-dose exposure include gastrointestinal upset and changes in the balance of fluids and electrolytes. There is also a risk of crystalluria, which is the formation of crystals in the urine, and convulsions, particularly in patients with impaired kidney function.

Q: Why is it important to store Clamoxin powder and tablets at room temperature?

A: The dry forms of the medication (powder and tablets) are required to be stored at a controlled room temperature, typically 20 C to 25 C. This specific instruction is essential to help maintain the chemical stability and potency of the active ingredients over their shelf life. The reconstituted liquid form, however, must be refrigerated for its stability.

Q: How quickly does Clamoxin usually start working?

A: Official pharmacokinetics data from regulatory documents describe how the drug moves through the body. Maximum concentrations of the amoxicillin component in the bloodstream are typically reached about one hour after an oral dose is taken. This indicates the time needed for the medicine to be absorbed.

Q: Do many people experience tiredness when taking Clamoxin?

A: Official listings of reported side effects include dizziness and headaches, which are described as uncommon effects. This means they affect less than 1 in 100 people. Tiredness or fatigue is generally not listed as a common or frequently reported adverse event.

Q: Can Clamoxin affect my sleep?

A: The regulatory list of side effects includes rare central nervous system effects. These rare events, which affect a very small number of users, include anxiety, insomnia (difficulty sleeping), and agitation.

Q: Is Clamoxin safe to take with common pain relievers like ibuprofen?

A: Official drug interaction lists specify known interactions with certain medications like probenecid and oral anticoagulants. No specific interaction is officially listed between this medication and commonly used non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen.

Q: Does Clamoxin interact with caffeine or alcohol?

A: Official labeling does not contain a specific interaction or warning regarding caffeine consumption. For alcohol, while a specific contraindication is not always listed, regulatory advice generally suggests avoiding or limiting use with any antibiotic to minimize the risk of increased side effects like nausea.

Q: Has Clamoxin been studied for use during pregnancy?

A: Official documentation addresses use in specific populations and typically assigns a pregnancy category. Use during pregnancy is generally considered only when the potential benefit to the mother is determined to outweigh any potential risk to the fetus. Animal studies may have shown no evidence of harm.

Q: Is it normal to feel a mild headache when starting Clamoxin?

A: Official listings include headache as an uncommon side effect. This means that based on clinical trials, it may affect up to 1 in 100 people who use the medicine.

Q: How long does Clamoxin stay in the body after I stop taking it?

A: The elimination half-life of the active components is approximately one hour in individuals with normal kidney function. Based on pharmacology principles, drugs are considered to be almost completely eliminated after a period corresponding to several half-lives.

Q: Does Clamoxin have a risk of dependence according to official documents?

A: Official regulatory documentation addresses the potential for abuse and dependence for this medication. It specifically states that there is no known risk of dependence, abuse, or tolerance associated with the use of this class of medication.

Q: What is the difference between Clamoxin and its generic version?

A: According to regulatory bodies, a generic product contains the same active ingredients and is required to be bioequivalent to the brand-name product. This means the generic must deliver the same amount of drug into the bloodstream over the same period, ensuring equivalent effectiveness.

Q: Can I drive or operate machinery while using Clamoxin?

A: Official labeling states that the medication may cause side effects, such as dizziness or rare convulsions, that could potentially affect a person's ability to drive or operate machinery. Regulatory labeling indicates that awareness of one’s individual response to the medication is important before performing such activities.

Q: What are the official warnings about potential mood changes with Clamoxin?

A: Rare central nervous system side effects have been reported in regulatory documents. These include changes in mood and behavior, such as agitation, anxiety, hyperactivity, and confusion.

Q: Is it necessary to finish all of the Clamoxin prescription?

A: Regulatory documentation strongly emphasizes the importance of taking the full course of treatment as prescribed. Stopping early may allow remaining bacteria to survive, which carries the risk of resistance and potential recurrence of the infection.

Q: What is the purpose of the inactive ingredients listed in Clamoxin?

A: Inactive ingredients, also known as excipients, are listed in official product descriptions. These substances are included to help stabilize the active drugs, hold the tablet together, ensure proper absorption, or provide color and flavor. They do not have a therapeutic effect.

Q: What is the official guidance on taking Clamoxin with dairy products?

A: Official drug documentation does not contain warnings to specifically avoid dairy products while taking this medication. The general instruction is to take the dose at the start of a meal to help minimize stomach upset.

Q: Can I take Clamoxin if I am breastfeeding?

A: Regulatory information indicates that both active components of the drug are excreted into breast milk. Regulatory documentation states that the potential benefit to the mother must be evaluated against any potential risk to the breastfed infant before use during this period.

Q: How is the safety of Clamoxin tracked after it is released to the public?

A: Regulatory bodies require ongoing monitoring of drug safety after approval through pharmacovigilance programs. This involves collecting and evaluating reports of adverse events submitted by healthcare professionals and the public to ensure the medication's safety profile remains understood throughout its use.

Q: Are there known populations where Clamoxin is less effective?

A: Official documents note that in patients with severe renal impairment (poor kidney function), doses must be carefully adjusted. This adjustment is necessary because poor clearance can lead to drug accumulation, which can affect both the safety and the overall effectiveness of the treatment.

Q: What is the official statement on alcohol consumption with Clamoxin?

A: While a specific, absolute contraindication for alcohol is not listed in regulatory documentation, patient guidance generally advises that limiting or avoiding alcohol intake may help minimize the risk of increased side effects, such as nausea and dizziness.

How should Clamoxin be stored and disposed of?

Official Storage and Handling Requirements

Clamoxin (amoxicillin and clavulanate potassium) tablets and dry powder must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F). All forms must be kept in the original container, which should be tightly closed to protect the contents from moisture.

The reconstituted liquid suspension must be stored in a refrigerator (2 C to 8 C) and must not be frozen. Any unused portion of the liquid suspension must be discarded after 10 days of refrigerated storage to maintain stability. Consistent with regulatory requirements, the medication must be stored out of the sight and reach of children.

Disposal

Expired or unused Clamoxin must be disposed of properly, typically through a local drug take-back program. If a program is unavailable, official guidelines recommend mixing the product with an undesirable substance (e.g., used coffee grounds) and placing it in a sealed container before discarding it in the household trash. The medication must not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clamoxin found in:

A-Z Index: